DEVELOPMENT OF RADIOLIGANDS FOR THE IMAGING OF CARDIAC BETA-ADRENOCEPTORS USING SPECT .2. PHARMACOLOGICAL CHARACTERIZATION IN-VITRO AND IN-VIVO OF NEW I-123 LABELED BETA-ADRENOCEPTOR ANTAGONISTS
Ea. Dubois et al., DEVELOPMENT OF RADIOLIGANDS FOR THE IMAGING OF CARDIAC BETA-ADRENOCEPTORS USING SPECT .2. PHARMACOLOGICAL CHARACTERIZATION IN-VITRO AND IN-VIVO OF NEW I-123 LABELED BETA-ADRENOCEPTOR ANTAGONISTS, Nuclear medicine and biology, 24(1), 1997, pp. 9-13
Cardiac beta-adrenoceptors are assumed to play a key role in chronic h
eart failure. Although several radioligands labeled with C-11 or F-18
have been synthesized for imaging purposes with positron emission tomo
graphy (PET), so far no optimal ligands are available to image cardiac
beta-adrenoceptors using single photon emission tomography (SPECT), I
n the present study, we characterized four new synthesized analogues o
f the nonselective p-adrenoceptor antagonist -t-butylamino-2-hydroxypr
opoxy)-benzimidazol-2-one (CGP12177) and one analogue of the nonselect
ive beta-adrenoceptor antagonist penbutolol. Using classical in vitro
displacement studies with left ventricular tissue of New Zealand White
rabbits and [I-125] iodocyanopindolol as a radioligand, binding affin
ity to the receptor was determined. From the four analogues, only (2'S
,2''E)- [4-(3'-(1'', yl-3''-Iodo-2''propenylamino)-2'-hydroxypropoxy)]
- benzimidazol-2-one proved to have a high affinity, with K-i = 1.25 /- 0.09 nM, n = 3. The other analogues showed relatively low affinity,
with K-i-values > 1 nM. The analogue of penbutolol (2-Iodophenoxy)]-3
'-(tert-butylamino)-2'-propanol) also showed a K-i value of 0.64 +/- 0
.26 nM, n = 3. Subsequently (2'S,2''E)-[4-(3'-( 1'', 1''-dimethyl-3''-
Iodo-2''propenylamino)one and -(2-Iodophenoxy)]-3'-(tert-butylamino)-2
'-propanol were radioactively labeled with I-123 to study their biodis
tribution in New Zealand White rabbits and to determine specific bindi
ng. Significant uptake was observed in both lungs and left ventricles.
However, both compounds showed high nonspecific binding in vivo becau
se uptake of the radioligand could not be inhibited by preinjection of
different (selective and nonselective-adrenoceptor antagonists and hy
drophilic and lipophilic antagonists) antagonists. In conclusion, alth
ough two analogues showed reasonable affinity in vitro for the recepto
r, their binding in vivo proved to be largely nonspecific, suggesting
that these two compounds are unsuitable for imaging purposes. However,
because marked differences in affinity for the receptor were observed
with only little structural changes between compounds, the present re
sults offer future perspectives for the synthesis of a more specific r
adioligand. Copyright (C) 1997 Elsevier Science Inc.